Gregory A. Kopia
Retired and self-directed
- Role
- Director of Preclinical Development - Focal Therapies at Orchestra BioMed
- Location
- Hillsborough, NJ, US
- LinkedIn followers
- 500 followers
About Gregory A. Kopia
Extensive experience in cardiovascular drug, device, and technology discovery research and development at both large and small company levels. Co-inventor of the Cypher Stent, the first commercially successful drug-device combination product for use in coronary artery disease. I can provide service in senior research management or in another research-associated area of the R&D process focused on pharmaceutical discovery research or drug/device combinations. Specialties: In vivo pre-clinical efficacy and safety of cardiovascular drugs, intravascular devices (stents) and drug device combinations; management of external contract laboratories; development of new novel stent drug formulations; local drug delivery; statistical evaluation of preclinical data; pharmacokinetics; scientific and medical writing; cardiovascular animal models; knowledge of relevant patent art; provide and summarize preclinical study data for FDA submissions; respond to FDA regarding preclinical data issues; conduct due diligence for business development.
Experience
Director of Preclinical Development - Focal Therapies
Aug 2018 — Present · New Hope, PA, US
Education
University of Michigan Medical School
Postdoctoral Fellow, Pharmacology
1980 — 1983
Gettysburg College
BA, Biology
1967 — 1971
University of Medicine and Dentistry of New Jersey -New Jersey Medical School
Ph.D., Pharmacology
1976 — 1980
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.